ArticleCancer immunology, immunotherapy : CII2023

Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor.

Yunpeng Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.